GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » Total Assets

Cantel Medical (Cantel Medical) Total Assets : $2,031 Mil (As of Apr. 2021)


View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical Total Assets?

Cantel Medical's Total Assets for the quarter that ended in Apr. 2021 was $2,031 Mil.

Warning Sign:

If a company builds asset at 22.3% a year, faster than its revenue growth rate of 10.8% over the past 5 years, it means that the company may be getting less efficent.

During the past 12 months, Cantel Medical's average Total Assets Growth Rate was -8.30% per year. During the past 3 years, the average Total Assets Growth Rate was 33.90% per year. During the past 5 years, the average Total Assets Growth Rate was 22.30% per year. During the past 10 years, the average Total Assets Growth Rate was 20.20% per year.

During the past 13 years, Cantel Medical's highest 3-Year average Total Assets Growth Rate was 59.30%. The lowest was -10.20%. And the median was 16.20%.

Total Assets is connected with ROA %. Cantel Medical's annualized ROA % for the quarter that ended in Apr. 2021 was 4.14%. Total Assets is also linked to Revenue through Asset Turnover. Cantel Medical's Asset Turnover for the quarter that ended in Apr. 2021 was 0.15.


Cantel Medical Total Assets Historical Data

The historical data trend for Cantel Medical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantel Medical Total Assets Chart

Cantel Medical Annual Data
Trend Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 694.53 786.37 963.71 1,070.37 2,071.75

Cantel Medical Quarterly Data
Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,912.37 2,071.75 2,040.50 2,050.31 2,031.28

Cantel Medical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cantel Medical's Total Assets for the fiscal year that ended in Jul. 2020 is calculated as

Total Assets=Total Equity (A: Jul. 2020 )+Total Liabilities (A: Jul. 2020 )
=729.599+1342.155
=2,072

Cantel Medical's Total Assets for the quarter that ended in Apr. 2021 is calculated as

Total Assets=Total Equity (Q: Apr. 2021 )+Total Liabilities (Q: Apr. 2021 )
=817.19+1214.088
=2,031

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantel Medical  (NYSE:CMD) Total Assets Explanation

Total Assets is connected with ROA %.

Cantel Medical's annualized ROA % for the quarter that ended in Apr. 2021 is

ROA %=Net Income (Q: Apr. 2021 )/( (Total Assets (Q: Jan. 2021 )+Total Assets (Q: Apr. 2021 ))/ count )
=84.472/( (2050.31+2031.278)/ 2 )
=84.472/2040.794
=4.14 %

Note: The Net Income data used here is four times the quarterly (Apr. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cantel Medical's Asset Turnover for the quarter that ended in Apr. 2021 is

Asset Turnover
=Revenue (Q: Apr. 2021 )/( (Total Assets (Q: Jan. 2021 )+Total Assets (Q: Apr. 2021 ))/ count )
=313.953/( (2050.31+2031.278)/ 2 )
=313.953/2040.794
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cantel Medical Total Assets Related Terms

Thank you for viewing the detailed overview of Cantel Medical's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantel Medical (Cantel Medical) Business Description

Traded in Other Exchanges
N/A
Address
150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424
Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.
Executives
Ann E Berman director 255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann officer: SVP, General Counsel 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades director, officer: Chief Executive Officer 281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker director, 10 percent owner, officer: Chairman ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman officer: SVP - CFO C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner officer: SVP and CHRO 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone officer: SVP and Princ. Accounting Ofr 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford officer: President and COO 40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin officer: Executive Vice President 150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese director 849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost director JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin director C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers director TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin director 399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316